LikeMinds

Executive Summary

LikeMinds is a US-based digital health company founded in 2019, specializing in AI-powered platforms for the diagnosis and treatment of mental health and neurological conditions, particularly tremor and dementia disorders. The company aims to deliver accurate, affordable, and accessible brain health solutions, leveraging artificial intelligence to address critical gaps in current diagnostic and therapeutic approaches. As a private, early-stage innovator in the rapidly growing digital health sector, LikeMinds is positioned to capitalize on the increasing demand for technology-driven mental healthcare, though it currently lacks disclosed funding, valuation, or pipeline details, indicating a need for further validation and market traction. The company's focus on tremor and dementia aligns with significant unmet needs in neurology, where AI-based tools can enhance early detection and monitoring. However, without public information on clinical progress or regulatory milestones, the risk profile remains elevated. LikeMinds' success will depend on its ability to secure funding, achieve regulatory clearances, and form strategic partnerships to commercialize its platforms. While the concept is promising, the lack of tangible metrics suggests a cautious outlook pending further development.

Upcoming Catalysts (preview)

• Q4 2026FDA clearance for tremor assessment platform30% success
• Q3 2026Series A funding round announcement40% success
• 2027Strategic partnership with healthcare provider for dementia AI20% success